-
Product Insights
NewMitogen Activated Protein Kinase 3 – Drugs In Development, 2024
The Mitogen Activated Protein Kinase 3 pipeline drugs market research report outlays comprehensive information on the Mitogen Activated Protein Kinase 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Genetic Disorders, and Cardiovascular which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Psoriasis, Neurofibromatoses Type I (Von Recklinghausen's Disease), and Hypertension. It also reviews...
-
Product Insights
NewSignal Transducer And Activator Of Transcription 5 – Drugs In Development, 2024
The Signal Transducer And Activator Of Transcription 5 pipeline drugs market research report outlays comprehensive information on the Signal Transducer And Activator Of Transcription 5 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Respiratory, Dermatology, and Toxicology which include indications of Leukemia, Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia), Idiopathic Pulmonary Fibrosis, Allergic Asthma, Atopic Dermatitis...
-
Product Insights
NewORAI Calcium Release Activated Calcium Modulator – Drugs In Development, 2024
The ORAI Calcium Release Activated Calcium Modulator pipeline drugs market research report outlays comprehensive information on the ORAI Calcium Release Activated Calcium Modulator targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Gastrointestinal, Central Nervous System, Infectious Disease, and Oncology which include indications of Pancreatitis, Ulcerative Colitis, Alzheimer's Disease, Multiple Sclerosis, Unspecified Viral Infections, Sepsis, Breast Cancer, and...
-
Product Insights
NewMAP Kinase Activated Protein Kinase 2 – Drugs In Development, 2024
The MAP Kinase Activated Protein Kinase 2 pipeline drugs market research report outlays comprehensive information on the MAP Kinase Activated Protein Kinase 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Musculoskeletal Disorders, Oncology, Immunology, and Respiratory which include indications of Ankylosing Spondylitis (Bekhterev's Disease), Psoriatic Arthritis, Bladder Cancer, Head And Neck Cancer, Rheumatoid Arthritis, and Acute...
-
Product Insights
NewMitogen Activated Protein Kinase Interacting Kinase – Drugs In Development, 2024
The Mitogen Activated Protein Kinase Interacting Kinase pipeline drugs market research report outlays comprehensive information on the Mitogen Activated Protein Kinase Interacting Kinase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, and Dermatology which include indications of Triple-Negative Breast Cancer (TNBC), Non-Small Cell Lung Cancer, Migraine, Neuropathic Pain (Neuralgia), and Dermatology. It also...
-
Product Insights
NewMitogen Activated Protein Kinase Kinase Kinase – Drugs In Development, 2024
The Mitogen Activated Protein Kinase Kinase Kinase pipeline drugs market research report outlays comprehensive information on the Mitogen Activated Protein Kinase Kinase Kinase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Gastrointestinal, Cardiovascular, and Central Nervous System which include indications of Oncology, Metastatic Melanoma, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Liver Fibrosis, Myocardial Infarction, Pulmonary Hypertension, Neurology, and...
-
Product Insights
NewCalcium Release Activated Calcium Channel Protein 1 – Drugs In Development, 2024
The Calcium Release Activated Calcium Channel Protein 1 pipeline drugs market research report outlays comprehensive information on the Calcium Release Activated Calcium Channel Protein 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Gastrointestinal, Infectious Disease, Oncology, and Respiratory which include indications of Pancreatitis, Ulcerative Colitis, Unspecified Viral Infections, Sepsis, Breast Cancer, Ovarian Cancer, Cystic Fibrosis, and...
-
Product Insights
NewMitogen Activated Protein Kinase Kinase Kinase 5 – Drugs In Development, 2024
The Mitogen Activated Protein Kinase Kinase Kinase 5 pipeline drugs market research report outlays comprehensive information on the Mitogen Activated Protein Kinase Kinase Kinase 5 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Gastrointestinal, Cardiovascular, Central Nervous System, and Genito Urinary System which include indications of Metabolic Dysfunction-Associated Steatohepatitis (MASH), Liver Fibrosis, Myocardial Infarction, Pulmonary Hypertension, Neurology,...
-
Product Insights
NewMitogen Activated Protein Kinase Kinase Kinase Kinase – Drugs In Development, 2024
The Mitogen Activated Protein Kinase Kinase Kinase Kinase pipeline drugs market research report outlays comprehensive information on the Mitogen Activated Protein Kinase Kinase Kinase Kinase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Infectious Disease, Cardiovascular, and Central Nervous System which include indications of Solid Tumor, Unspecified Cancer, Human Immunodeficiency Virus (HIV) Infections (AIDS), Hepatitis B,...
-
Product Insights
NewDual Specificity Mitogen Activated Protein Kinase Kinase 1 – Drugs In Development, 2024
The Dual Specificity Mitogen Activated Protein Kinase Kinase 1 pipeline drugs market research report outlays comprehensive information on the Dual Specificity Mitogen Activated Protein Kinase Kinase 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Genetic Disorders, Non Malignant Disorders, and Central Nervous System which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Neurofibromatoses Type...